2-phenylaminoadenosine stimulates dopamine synthesis in rat forebrain in vitro and in vivo via adenosine A2 receptors

Brain Research

Volumn 761, Issue 1, 1997, Pages 151-155

  Choksi, Neepa Y ^a   Hussain, Anwar ^a   Booth, Raymond G ^a  

^a Dept of Environ Sci and Eng   (United States)

Author keywords

Adenosine receptor; Adenylyl cyclase; Brain; Dopamine; Tyrosine hydroxylase

Indexed keywords

2 ANILINOADENOSINE; ADENOSINE A2 RECEPTOR; ADENYLATE CYCLASE; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; ENZYME ACTIVITY; FOREBRAIN; MENTAL DISEASE; NONHUMAN; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; STROKE;

ADENOSINE; ADENYLATE CYCLASE; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; NEOSTRIATUM; NEURONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; TYROSINE 3-MONOOXYGENASE; VASODILATOR AGENTS;

EID: 0030788422     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00445-9     Document Type: Article

References (32)

1. Baldessarini R.J., Marsh E.R., Kula N.S., Zong R., Gao Y., Neumeyer J.L. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Biochem. Pharmacol. 40:1990;417-423.
2. 2 autoreceptor activation. Eur. J. Pharmacol. 185:1990;217-221.
3. Booth R.G., Baldessarini R.J., Kula N.S., Zong R., Gao Y., Neumeyer J.L. Presynaptic inhibition of striatal dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Mol. Pharmacol. 38:1990;92-101.
4. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29:1986;331-346.
5. Daly J.W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 3:1983;69-80.
6. Fastbom J., Pazos A., Palacios J.M. The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22:1987;813-826.
7. Fredholm B.B. Purinoceptors in the nervous system. Pharmacol. Toxicol. 76:1995;228-239.
8. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
9. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit release? Trends Pharmacol. Sci. 9:1988;130-134.
10. Haycock J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem. 265:1990;11682-11691.
11. Haycock J.W., Haycock D.A. Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: multiple-site phosphorylation in vivo and in synaptosomes. J. Biol. Chem. 266:1991;5650-5657.
12. 2-selective adenosine antagonists. J. Med. Chem. 36:1993;1333-1342.
13. 2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323:1993;141-144.
14. 3H]CGS 21680. Eur. J. Pharmacol. 168:1989;243-246.
15. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:1994;298-306.
16. 3 receptor with widespread tissue distribution. Proc. Natl. Acad. Sci. USA. 44:1993;524-532.
17. Moser A., Liebetrau A., Cramer H. Adenosine receptor-coupled adenylate cyclase in the caudate nucleus of the rat brain. Neuropharmacology. 30:1991;769-773.
18. Myers S., Pugsley T.A. Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists. Brain Res. 375:1986;193-197.
19. 6-(R)-phenylisopropyladenosine (R-PIA) inhibits forskolin-stimulated tyrosine hydroxylase activity in rat striatal synaptosomes. Life Sci. 46:1990;591-598.
20. 2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Life Sci. 456:1988;302-309.
21. 1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8:1996;1176-1181.
22. 2+ sensitive adenylate cyclase. Mol. Pharmacol. 13:1977;662-670.
23. Rivkees S.A. Localization and characterization of adenosine receptor expression in rat testis. Endocrinology. 135:1994;2307-2313.
24. Salah R.S., Kuhn D.M., Galloway M.P. Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices. J. Neurochem. 52:1989;1517-1522.
25. 1 dopamine receptors. Brain Res. 519:1990;333-337.
26. 2 receptor mRNA in the human brain. Neurosci. Lett. 130:1991;177-181.
27. Shultz D.W., Mailman R.B. An improved, automated adenylate cyclase assay utilizing preparative HPLC: effects of phosphodiesterase inhibitors. J. Neurochem. 42:1984;764-774.
28. Van Calker D., Muller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33:1979;999-1005.
29. Walters J.R., Roth R.H. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 296:1976;5-14.
30. Wolf M.E., Roth R.H. Autoreceptor regulation of dopamine synthesis. Ann. NY Acad. Sci. 604:1990;323-342.
31. Zetterstrom T., Fillenz M. Adenosine agonists can inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 180:1990;137-143.
32. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA. 89:1992;7432-7436.